There was a strong trend towards improved survival in the combination group at 28-days, but the difference was not statistically significant (30 % vs 20 %, P = 0.054) [ 53 ].
← all excerpts
Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection: How Close Are We?
1
—
—